Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint

Authors

Lindsay M. Avery
Joseph L. Kuti
Maja Weisser
Adrian Egli
Michael J. Rybak
Evan J. Zasowski, Touro University CaliforniaFollow
Cesar A. Arias
German A. Contreras
Pearlie P. Chong
Samuel L. Aitken
Adam J. DiPippo
Jann-Tay Wang
Nicholas S. Britt
David P. Nicolau

Publication Date

5-2019

DOI

10.1093/cid/ciy749

Recommended Citation

Avery, L. M., Kuti, J. L., Weisser, M., Egli, A., Rybak, M. J., Zasowski, E. J., Arias, C. A., Contreras, G. A., Chong, P. P., Aitken, S. L., DiPippo, A. J., Wang, J.-T., Britt, N. S., & Nicolau, D. P. (2019). Pharmacodynamic Analysis of Daptomycin-Treated Enterococcal Bacteremia: It Is Time to Change the Breakpoint. Clinical Infectious Diseases, 68(10), 1650–1657. https://doi.org/10.1093/cid/ciy749